海鱼分支杆菌对Dihydromycoplanecin和另外十种抗菌剂敏感性的体外试验

来源 :国外医学.皮肤病学分册 | 被引量 : 0次 | 上传用户:n62315942
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
海鱼分支杆菌主要感染皮肤,在日本占皮肤非典型分支杆菌感染的81.5%.流行病学上称之为“游泳池肉芽肿”.症状包括:慢性化脓性肉芽肿、结节、浸润性斑块以及硬结、脓肿和溃疡.本文报告了11种抗海鱼分支杆菌药物的最小抑菌浓度(MICs).取经过鉴定的16株分离的海鱼分支杆菌.11种药物为:dihydromycoplanecin A (DHMPA)、丁胺卡那霉素(AMK)、二甲胺四环素(MINO)、土霉素(OXTC)、氟嗪酸(OFLX)、氟哌酸(NFLX)、氟啶酸(ENX)、磺胺甲基异恶唑(SMX)、三甲氧苄氨嘧啶(T Mycobacterium maritima infects the skin, which accounts for 81.5% of the skin’s atypical mycobacteria infections in Japan, which is epidemiologically referred to as “granuloma of the swimming pool.” Symptoms include chronic pyogenic granulomas, nodules, Lumps, as well as induration, abscesses and ulcers.This article reports the minimum inhibitory concentrations (MICs) of 11 antimicrobial drugs against Mycobacterium marinus, including 16 isolates of Mycobacterium maritima identified as dihydromycoplanecin A (DHMPA), Amikacin (AMK), Minocycline (MINO), Oxytetracycline (OXTC), OFLX, NFLX, ENX, Oxazole (SMX), trimethoprim (T
其他文献